NicoDerm CQ, a sticky patch that adhered to the skin and delivered a steady flow of nicotine to help ease the physical withdrawal symptoms associated with quitting smoking, was introduced by its manufacturer, the pharmaceutical company SmithKline Beecham, as a prescription drug in 1991.
GlaxoSmithKline plc: Power To Quit campaign
Rebecca StanfelOVERVIEW
NOTE: Since the initial appearance of this essay in the 1998 edition of Major Marketing Campaigns Annual, SmithKline Beecham merged with Glaxo to form GlaxoSmithKline plc. The essay continues...
